Search research articles
Contact Us
Filters
Showing results (141-150 of 155) with videos related to
Page
of 16
Sort By:
BMJ (Clinical Research Ed.)
|
August 2, 2015
Long term outcomes of transplantation using kidneys from expanded criteria donors: prospective, population based cohort study
Olivier Aubert, Nassim Kamar, Dewi Vernerey, et al.
BMC Cancer
|
April 27, 2020
Atezolizumab plus modified docetaxel-cisplatin-5-fluorouracil (mDCF) regimen versus mDCF in patients with metastatic or unresectable locally advanced recurrent anal squamous cell carcinoma: a randomized, non-comparative phase II SCARCE GERCOR trial
Stefano Kim, Bruno Buecher, Thierry André, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 7, 2022
Second-line treatment after docetaxel, cisplatin and 5-fluorouracil in metastatic squamous cell carcinomas of the anus. Pooled analysis of prospective Epitopes-HPV01 and Epitopes-HPV02 studies
Morgane Stouvenot, Aurélia Meurisse, Angélique Saint, et al.
The Lancet. Oncology
|
July 26, 2018
Docetaxel, cisplatin, and fluorouracil chemotherapy for metastatic or unresectable locally recurrent anal squamous cell carcinoma (Epitopes-HPV02): a multicentre, single-arm, phase 2 study
Stefano Kim, Eric François, Thierry André, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 4, 2015
Adjuvant Fluorouracil, Leucovorin, and Oxaliplatin in Stage II to III Colon Cancer: Updated 10-Year Survival and Outcomes According to BRAF Mutation and Mismatch Repair Status of the MOSAIC Study
Thierry André, Armand de Gramont, Dewi Vernerey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 7, 2022
Safety, Immunogenicity, and 1-Year Efficacy of Universal Cancer Peptide-Based Vaccine in Patients With Refractory Advanced Non-Small-Cell Lung Cancer: A Phase Ib/Phase IIa De-Escalation Study
Olivier Adotévi, Dewi Vernerey, Pascale Jacoulet, et al.
Therapeutic Advances in Medical Oncology
|
December 17, 2020
Pooled analysis of 115 patients from updated data of Epitopes-HPV01 and Epitopes-HPV02 studies in first-line advanced anal squamous cell carcinoma
Stefano Kim, Aurélia Meurisse, Laurie Spehner, et al.
European Urology Oncology
|
August 14, 2024
Pain and Health-related Quality of Life with Biweekly Versus Triweekly Cabazitaxel Schedule in Older Men with Metastatic Castration-resistant Prostate Cancer in the Multicenter, Randomized CABASTY Trial
Stephane Oudard, Yohann Tran, Carole Helissey, et al.
Nature Medicine
|
January 7, 2026
Soluble MAdCAM-1 as a biomarker in metastatic renal cell carcinoma
Carolina Alves Costa Silva, Marc Machaalani, Renee Maria Saliby, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 27, 2024
A multicenter study evaluating efficacy of immune checkpoint inhibitors in advanced non-colorectal digestive cancers with microsatellite instability
Mathilde Moreau, Emily Alouani, Clémence Flecchia, et al.
Page
of 16
Search research articles
Search
Showing results (141-150 of 155) with videos related to
Sort By:
Page
of 16
BMJ (Clinical Research Ed.)
|
August 2, 2015
Long term outcomes of transplantation using kidneys from expanded criteria donors: prospective, population based cohort study
Olivier Aubert, Nassim Kamar, Dewi Vernerey, et al.
BMC Cancer
|
April 27, 2020
Atezolizumab plus modified docetaxel-cisplatin-5-fluorouracil (mDCF) regimen versus mDCF in patients with metastatic or unresectable locally advanced recurrent anal squamous cell carcinoma: a randomized, non-comparative phase II SCARCE GERCOR trial
Stefano Kim, Bruno Buecher, Thierry André, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 7, 2022
Second-line treatment after docetaxel, cisplatin and 5-fluorouracil in metastatic squamous cell carcinomas of the anus. Pooled analysis of prospective Epitopes-HPV01 and Epitopes-HPV02 studies
Morgane Stouvenot, Aurélia Meurisse, Angélique Saint, et al.
The Lancet. Oncology
|
July 26, 2018
Docetaxel, cisplatin, and fluorouracil chemotherapy for metastatic or unresectable locally recurrent anal squamous cell carcinoma (Epitopes-HPV02): a multicentre, single-arm, phase 2 study
Stefano Kim, Eric François, Thierry André, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 4, 2015
Adjuvant Fluorouracil, Leucovorin, and Oxaliplatin in Stage II to III Colon Cancer: Updated 10-Year Survival and Outcomes According to BRAF Mutation and Mismatch Repair Status of the MOSAIC Study
Thierry André, Armand de Gramont, Dewi Vernerey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 7, 2022
Safety, Immunogenicity, and 1-Year Efficacy of Universal Cancer Peptide-Based Vaccine in Patients With Refractory Advanced Non-Small-Cell Lung Cancer: A Phase Ib/Phase IIa De-Escalation Study
Olivier Adotévi, Dewi Vernerey, Pascale Jacoulet, et al.
Therapeutic Advances in Medical Oncology
|
December 17, 2020
Pooled analysis of 115 patients from updated data of Epitopes-HPV01 and Epitopes-HPV02 studies in first-line advanced anal squamous cell carcinoma
Stefano Kim, Aurélia Meurisse, Laurie Spehner, et al.
European Urology Oncology
|
August 14, 2024
Pain and Health-related Quality of Life with Biweekly Versus Triweekly Cabazitaxel Schedule in Older Men with Metastatic Castration-resistant Prostate Cancer in the Multicenter, Randomized CABASTY Trial
Stephane Oudard, Yohann Tran, Carole Helissey, et al.
Nature Medicine
|
January 7, 2026
Soluble MAdCAM-1 as a biomarker in metastatic renal cell carcinoma
Carolina Alves Costa Silva, Marc Machaalani, Renee Maria Saliby, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 27, 2024
A multicenter study evaluating efficacy of immune checkpoint inhibitors in advanced non-colorectal digestive cancers with microsatellite instability
Mathilde Moreau, Emily Alouani, Clémence Flecchia, et al.
Page
of 16